- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
- You can view the full Johnson & Johnson Ratings Report.
The New Brunswick, N.J.-based company noted that its pharma sales dipped due to weakness in the U.S. compared to other markets.
Healthcare expenses will surge, but so will several other categories.
From making shoes to medical devices, manufacturing is becoming personal.
The S&P 500 is trading at historically overvalued levels after the Trump rally of the last five months. These 10 stocks are likely to thrive during the next recession.